A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease

Characterisation and diagnosis of idiopathic Parkinson’s disease (iPD) is a current challenge that hampers both clinical assessment and clinical trial development with the potential inclusion of non-PD cases. Here, we used a targeted mass spectrometry approach to quantify 38 metabolites extracted fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Klatt, Stephan, Doecke, James D., Roberts, Anne, Boughton, Berin A., Masters, Colin L., Horne, Malcolm, Roberts, Blaine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516864/
https://www.ncbi.nlm.nih.gov/pubmed/34650080
http://dx.doi.org/10.1038/s41531-021-00239-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516864/
https://www.ncbi.nlm.nih.gov/pubmed/34650080
http://dx.doi.org/10.1038/s41531-021-00239-x

Ejemplares similares